|
|
Volumn 120, Issue 3 SUPPL., 2001, Pages 94S-98S
|
|
Formulation of aerosolized therapeutics
|
|
Author keywords
Aerosolized; Bronchiectasis; Cystic fibrosis; Pseudomonas aeruginosa
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B;
ANTIBIOTIC AGENT;
ANTIINFLAMMATORY AGENT;
BETA LACTAM ANTIBIOTIC;
BRONCHODILATING AGENT;
CARBENICILLIN;
CEFTAZIDIME;
COLISTIN;
COLISTIN SULFOMETHATE;
CORTICOSTEROID;
DRUG ADDITIVE;
GENTAMICIN;
INSULIN;
METHYL PARABEN;
MUCOLYTIC AGENT;
NEOMYCIN;
PENICILLIN G;
POLYMYXIN;
PRESERVATIVE;
PROPYL PARABEN;
QUINOLONE DERIVATIVE;
SODIUM CHLORIDE;
STABILIZING AGENT;
TICARCILLIN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
UNCLASSIFIED DRUG;
WATER;
ANTIBIOTIC THERAPY;
BACTERIAL COLONIZATION;
BRONCHIECTASIS;
BRONCHOSPASM;
CLINICAL TRIAL;
COUGHING;
CYSTIC FIBROSIS;
DRUG ACCUMULATION;
DRUG ACTIVITY;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG PENETRATION;
DRUG SAFETY;
DRUG SPUTUM LEVEL;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
NEBULIZATION;
NEPHROTOXICITY;
OTOTOXICITY;
PARTICLE SIZE;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
RESPIRATORY FAILURE;
REVIEW;
TREATMENT OUTCOME;
|
|
EID: 0034828531
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.120.3_suppl.94S Document Type: Article |
|
Times cited : (56)
|
|
References (17)
|
